Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

BACKGROUND: Hyperphosphatemia necessitates the use of phosphate binders in most dialysis patients. Long-term efficacy and tolerability of the iron-based phosphate binder, sucroferric oxyhydroxide (previously known as PA21), was compared with that of sevelamer carbonate (sevelamer) in an open-label P...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nephrol Dial Transplant
Main Authors: Floege, Jürgen, Covic, Adrian C., Ketteler, Markus, Mann, Johannes F.E., Rastogi, Anjay, Spinowitz, Bruce, Chong, Edward M.F., Gaillard, Sylvain, Lisk, Laura J., Sprague, Stuart M.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4438742/
https://ncbi.nlm.nih.gov/pubmed/25691681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados